Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

NCT03808922 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

274

Enrollment

INDUSTRY

Sponsor class

Conditions

Lower Respiratory Tract Infection
Parainfluenza
Immunocompromised
COVID-19

Interventions

DRUG: DAS181
DRUG: Placebo
DRUG: DAS181 COVID-19
DRUG: DAS181 OL

Sponsor

Ansun Biopharma, Inc.